Paul Hastings LLP has advised SK Biopharmaceuticals Co. Ltd.; Sullivan & Cromwell LLP has advised Biohaven Ltd. SK Biopharmaceuticals Co. Ltd. and Biohaven Ltd. have announced...
SK Biopharmaceuticals In-Licenses Opakalim from Biohaven in $795 Million Global Agreement
Francisco Partners Acquires Majority Stake in Command Alkon from Thoma Bravo
Paul Hastings LLP has advised Francisco Partners. Kirkland & Ellis LLP has advised Thoma Bravo and Command Alkon. Skadden, Arps, Slate, Meagher & Flom LLP has...
CaseWorthy Secures Majority Growth Investment from Rubicon Technology Partners
Paul Hastings LLP has advised CaseWorthy, a portfolio company of STG Partners, on securing a majority growth investment from Rubicon Technology Partners. CaseWorthy, a provider of...



























